Chikungunya Vaccine Drama in Europe

Europe just hit pause on Valneva’s new chikungunya vaccine for folks 65+ after some serious side effects popped up—including two deaths. The vaccine, which was supposed to protect against the mosquito-borne virus, is now under review. The company’s working with health authorities to figure out what’s going on, but for now, older adults are being told to skip it. Wild how fast things can change with new meds! #healthnews #vaccineupdate #chikungunya #Europe #Valneva #Health